MedTech Resources

PMA device

Simplera Sync Sensor, Guardian 4 Sensor

Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed

FDA decisions

1

PMA pathway

Device trials

1

Naming "Simplera Sync"

MAUDE reports

1,356

Brand "Simplera Sync", since 2015

PubMed studies

7

Mentioning "Simplera Sync"

AI summary across all sources

Written by Claude (Anthropic's AI) from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.

FDA decisions

The newest 1 of 1 decisions filed under this name.

Medicare coverage

National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.

How devices get paid for

No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.

Clinical trials

Device studies on ClinicalTrials.gov that name "Simplera Sync", any status and sponsor, newest update first.

Open in Trial Radar

Adverse event reports (MAUDE)

Reports received since 2015 naming the brand "Simplera Sync", and for the whole product code for context.

This brand

1,356 reports: 1,272 malfunction, 84 injury, 0 death

Whole product code SFI

5,905 reports: 5,762 malfunction, 143 injury, 0 death

Newest reports for this brand

All reports in MAUDE Monitor

Recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

No recall in FDA's data is linked to these FDA numbers.

Published research

The most relevant PubMed records for "Simplera Sync"[tiab]. The summary above synthesizes these.

PubMedGoogle ScholarLiterature search

Other devices of this type

Also filed under product code SFI.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.